Kodiak Sciences Inc has 8 Schedule 13D or 13G filings on record since 2025-08-19. 5 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 32.8% | 20,067,542 | SCHEDULE 13D/A, 2025-12-19 | 2025-12-18 |
| D. Victor Perlroth, M.D. | 9.9% | 6,504,427 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
| Sirenia Capital Management LP | 5.7% | 3,495,000 | SCHEDULE 13G, 2026-05-15 | 2026-03-31 |
| BlackRock, Inc. | 5.3% | 3,273,386 | SCHEDULE 13G, 2026-04-27 | 2026-03-31 |
| T. Rowe Price Associates, Inc. | 5.2% | 3,248,611 | SCHEDULE 13G, 2026-08-14 | 2026-06-30 |
| Point72 Asset Management, L.P. | 1% | 609,806 | SCHEDULE 13G, 2026-04-02 | 2026-03-26 |
Purpose of Transaction (Item 4)
Baker Bros. Advisors LP
Item 4 of Amendment No. 11 is supplemented and amended, as the case may be, as follows: The disclosure in Item 3 and in Item 6 below is incorporated herein by reference. On December 16, 2025, the Issuer entered into an underwriting agreement (the "Underwriting Agreement") with J.P. Morgan Securities LLC, Jefferies LLC, Evercore Group L.L.C. and UBS Securities LLC (the "Underwriters"), related to the public offering (the "Offering") of 6,956,522 shares of common stock of the Issuer ("Common Stock") at a price to the public of $23.00 per share. In addition, the Issuer granted the Underwriters an option exercisable for 30 days from the date of the Underwriting Agreement to purchase, at the public offering price less any underwriting discounts and commissions, up to an additional 1,043,478 shares of Common Stock to cover overallotments, if any ("Underwriters Option"), which the Underwriters exercised in full on December 18, 2025. The Offering closed on December 18, 2025. Pursuant to the Offering, 667 and Life Sciences purchased 217,428 and 2,391,268 shares of Common Stock, respectively, at the offering price of $23.00 per share, totaling 2,608,696 shares of Common Stock in the aggregate. Each of 667 and Life Sciences purchased the Common Stock with their working capital. The Funds hold securities of the Issuer for investment purposes. The Reporting Persons or their affiliates may purchase additional securities or dispose of securities in varying amounts and at varying times …The first part of Item 4 of the SCHEDULE 13D/A filed 2025-12-19; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-19 | Point72 Asset Management, L.P. | 5.5% | SCHEDULE 13G |
| 2025-12-19 | Baker Bros. Advisors LP | 32.8% | SCHEDULE 13D/A |
| 2026-02-17 | Point72 Asset Management, L.P. | 3.5% | SCHEDULE 13G/A |
| 2026-02-17 | D. Victor Perlroth, M.D. | 9.9% | SCHEDULE 13G/A |
| 2026-04-02 | Point72 Asset Management, L.P. | 1% | SCHEDULE 13G |
| 2026-04-27 | BlackRock, Inc. | 5.3% | SCHEDULE 13G |
| 2026-05-15 | Sirenia Capital Management LP | 5.7% | SCHEDULE 13G |
| 2026-08-14 | T. Rowe Price Associates, Inc. | 5.2% | SCHEDULE 13G |
Tools for this story
Each opens in a new tab, filled in for Kodiak Sciences Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.